These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6304822)

  • 1. [Hypoaldosteronism].
    Villabona C; Pallares R; Capell S; Busquets E
    Rev Clin Esp; 1983 Feb; 168(4):221-8. PubMed ID: 6304822
    [No Abstract]   [Full Text] [Related]  

  • 2. [Major endocrine diseases].
    Kato T
    Nihon Rinsho; 1982; 40(9):2041-7. PubMed ID: 6296489
    [No Abstract]   [Full Text] [Related]  

  • 3. [Idiopathic hyperaldosteronism and the related dexamethasone suppressive hyperaldosteronism].
    Yasuda K; Miura K
    Nihon Naika Gakkai Zasshi; 1992 Apr; 81(4):517-22. PubMed ID: 1320089
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of secondary hyperaldosteronism].
    Werning C; Siegenthaler W
    Dtsch Med Wochenschr; 1969 Oct; 94(40):2049-51. PubMed ID: 4311366
    [No Abstract]   [Full Text] [Related]  

  • 5. [Primary hyperaldosteronism-current theories].
    Chodakowska J; Januszewicz W
    Kardiol Pol; 1981; 24(7):519-25. PubMed ID: 7024613
    [No Abstract]   [Full Text] [Related]  

  • 6. [ Secondary hyperaldosteronism].
    Veyrat R; Muller AF; Mach RS
    Union Med Can; 1968 Sep; 97(9):1237-48. PubMed ID: 4320633
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperaldosteronism: primary versus tertiary.
    Stowasser M
    J Hypertens; 2002 Jan; 20(1):17-9. PubMed ID: 11791021
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary hyperaldosteronism and isolated hypoaldosteronism (lecture)].
    Egart FM
    Probl Endokrinol (Mosk); 1989; 35(2):54-8. PubMed ID: 2740317
    [No Abstract]   [Full Text] [Related]  

  • 9. [The renin-angiotensin system in critically ill patients--the incidence of hypoaldosteronism and its pathogenesis].
    Okamoto S; Miyamori I; Ikeda M; Nagai K; Koshida H; Takeda Y; Yasuhara S; Morise T; Takimoto H; Takeda R
    Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1599-604. PubMed ID: 3913790
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hyperaldosteronism].
    Rom-Boguslavskaia ES
    Sov Med; 1982; (4):62-9. PubMed ID: 7048558
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE; Montero J; Mosso L
    Rev Med Chil; 1999 May; 127(5):604-10. PubMed ID: 10451632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of long-term treatment of arterial hypertension with Ca antagonists on the renin-angiotensin-aldosterone system in diabetics. Hyporeninemic hypoaldosteronism].
    Hrnciar J; Jakubíková K; Hrnciarová M; Kreze A; Chamulová M
    Vnitr Lek; 1995 Oct; 41(10):661-6. PubMed ID: 8578695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperaldosteronism, spironolactone and liver cirrhosis].
    Sort P; Guevara M; Arroyo V
    Gastroenterol Hepatol; 1997 Mar; 20(3):151-9. PubMed ID: 9162537
    [No Abstract]   [Full Text] [Related]  

  • 14. [11-beta-hydroxylase deficiency and glucocorticoid-sensitive hyperaldosteronism].
    Merino Arribas JM; Rámila de la Torre E; Sánchez Martín J; Avellanosa Arnaiz A; González de la Rosa JB
    An Esp Pediatr; 1996 Jun; 44(6):609-11. PubMed ID: 8849112
    [No Abstract]   [Full Text] [Related]  

  • 15. Pseudohyperaldosteronism with renal tubular resistance to mineralocorticoid hormones.
    Rodriguez JA; Biglieri EG; Schambelan M
    Trans Assoc Am Physicians; 1981; 94():172-82. PubMed ID: 7046191
    [No Abstract]   [Full Text] [Related]  

  • 16. [Normokalemic primary hyperaldosteronism].
    Vonend O; Rump LC
    Dtsch Med Wochenschr; 2006 Nov; 131(46 Spec No):H24-7. PubMed ID: 17109245
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary aldosteronism.
    Corry DB; Tuck ML
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):511-29. PubMed ID: 8575407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyper- and hypoaldosteronism].
    Kalinin AP; Kulikov LK; Kozulin MA; Privalov IuA
    Klin Med (Mosk); 2008; 86(7):7-13. PubMed ID: 18756739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiological roles of the adrenal renin-angiotensin system in patients with primary aldosteronism.
    Oda N; Takeda Y; Zhu A; Usukura M; Yoneda T; Takata H; Mabuchi H
    Hypertens Res; 2006 Jan; 29(1):9-14. PubMed ID: 16715648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aldosteronoma with noticeable lymphocytic infiltration, a new isotype?].
    Cugini P; Lucia P; Letizia C; Murano G; Pieche S
    Minerva Endocrinol; 1984; 9(4):421-4. PubMed ID: 6535947
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.